BioScience Trends. 2013;7(3):157-158. (DOI: 10.5582/bst.2013.v7.3.157)
Perspectives on human clinical trials of therapies using iPS cells in Japan: Reaching the forefront of stem-cell therapies.
Song PP, Inagaki Y, Sugawara Y, Kokudo N
A research project involving sheets of retinal pigment epithelium constructed from iPS cells derived from patients with age-related maculopathy is one step closer to being approved for clinical trials by the Japanese Government. Now is the time to make therapies using iPS cells clinically available.